|
29.07.2013 22:05:00
|
Alexandria Real Estate Equities, Inc. Reports Second Quarter Ended June 30, 2013 Financial and Operating Results
PASADENA, Calif., July 29, 2013 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced financial and operating results for the second quarter ended June 30, 2013.
Second quarter ended June 30, 2013, highlights
Results
- Funds from operations ("FFO") attributable to Alexandria Real Estate Equities, Inc.'s ("Alexandria's") common stockholders – diluted, as adjusted:
- $71.6 million, or $1.07 per share, for 2Q13 compared to $65.8 million, or $1.07 per share, for 2Q12
- $141.6 million, or $2.18 per share, for YTD 2Q13 compared to $132.0 million, or $2.14 per share, for YTD 2Q12
- Adjusted funds from operations ("AFFO") attributable to Alexandria's common stockholders – diluted:
- $66.8 million, or $1.00 per share, for 2Q13 compared to $64.0 million, or $1.04 per share, for 2Q12
- $134.7 million, or $2.07 per share, for YTD 2Q13 compared to $126.4 million, or $2.05 per share, for YTD 2Q12
- Net income attributable to Alexandria's common stockholders – diluted:
- $25.5 million, or $0.38 per share, for 2Q13 compared to $17.6 million, or $0.29 per share, for 2Q12
- $47.9 million, or $0.74 per share, for YTD 2Q13 compared to $36.0 million, or $0.58 per share, for YTD 2Q12
Core operating metrics
- Total revenues from continuing operations:
- $154.2 million for 2Q13, up 5.9%, compared to $145.6 million for 2Q12
- $304.6 million YTD 2Q13, up 8.3%, compared to $281.3 million for YTD 2Q12
- Net operating income ("NOI") from continuing operations:
- $107.9 million for 2Q13, up 4.3%, compared to $103.5 million for 2Q12
- $213.1 million for YTD 2Q13, up 7.2%, compared to $198.7 million for YTD 2Q12
- Same property NOI performance:
- 7.2% and 3.2% increases on a cash and GAAP basis, respectively, for 2Q13 compared to 2Q12
- 8.3% and 2.0% increases on a cash and GAAP basis, respectively, for YTD 2Q13 compared to YTD 2Q12
- Leasing activity solid during the three months ended June 30, 2013:
- Executed 66 leases for 768,000 rentable square feet ("RSF"), including 270,000 RSF of development and redevelopment space
- Rental rate increase of 6.7% and 12.7% on a cash and GAAP basis, respectively, on renewed/re-leased space
- Key life science space leasing:
- Investment-grade entity leased 121,632 RSF at 430 East 29th Street development in the Greater NYC market
- Illumina, Inc. leased 97,702 RSF at 499 Illinois Street development in the San Francisco Bay Area market
- Sarepta Therapeutics, Inc. leased 46,376 RSF at 215 First Street in the Greater Boston market
- Eli Lilly and Company leased 27,950 RSF at 620 Professional Drive in the Suburban Washington, D.C. market
- Nominal remaining expiring leases in 2013 of 410,254 RSF, or 3% of total operating RSF
- Occupancy for North American Properties, as of June 30, 2013:
- 94.6% for operating properties and 92.9% for operating and redevelopment properties, up 40 bps and 110 bps, respectively, since March 31, 2013
- Operating margins remained steady at 70% for 2Q13 and YTD 2Q13
- Investment-grade client tenants represented 46% of total annualized base rent ("ABR")
- Investment-grade client tenants represented 72% of ABR from our top 10 client tenants
- Contractual annual rent escalations in 95% of our leases
Balance sheet
- Completed in 2Q13 secondary offering of 7.6 million shares of common stock at a price of $73.50 per share. The net proceeds of $535.5 million were used to repay outstanding balances under our unsecured senior line of credit.
- Completed in 2Q13 $500 million 3.90% 10-year unsecured senior notes payable offering. Net proceeds of $495.3 million were used to reduce outstanding variable rate bank debt, including a $150 million partial repayment of our $750 million 2016 Unsecured Senior Bank Term Loan and to increase our available cash balance. In connection with the partial repayment of our 2016 Unsecured Senior Bank Term Loan, we recognized a loss on the early extinguishment of debt related to the write-off of unamortized loan fees totaling $0.6 million, or $0.01 per share.
- Liquidity of $1.8 billion, including $1.5 billion available under our unsecured senior line of credit and $302.2 million in cash and cash equivalents as of June 30, 2013.
- Closed in 2Q13 secured construction loan, with aggregate commitments of $36 million at a rate of LIBOR + 1.40%, for 100% pre-leased development project at 269 East Grand Avenue in the San Francisco Bay Area market.
- Net debt to EBITDA of 6.6x for the twelve months ended June 30, 2013.
- Fixed charge coverage ratio of 2.7x for the twelve months ended June 30, 2013.
- Unhedged variable rate debt totaling 11% of total consolidated debt as of June 30, 2013.
- Completed in 2Q13 $22.5 million of real estate property sales, at a gain of $1.0 million, as follows:
- $4.4 million of non-strategic income producing assets at a gain of $0.2 million
- $18.1 million of non-income-producing land at a gain of $0.8 million
Subsequent events
Ariad Pharmaceuticals, Inc. expansion
On July 3, 2013, Ariad Pharmaceuticals, Inc. executed an LOI to lease an additional 139,374 RSF for a 15 year term at our 75/125 Binney Street development in the Cambridge submarket of Greater Boston. An amendment to their lease is under negotiation to increase their lease to 383,497 RSF, or 99% of the total RSF of the project.
Sale of land parcel at 1600 Owens Street
On July 8, 2013, we executed a purchase and sale agreement to dispose of our land parcel at 1600 Owens Street in the Mission Bay submarket of the San Francisco Bay Area for an aggregate sales price of $55.2 million, inclusive of certain parking spaces. Ownership of the parcel was strategically important to the buyer and we will earn a fee to manage the construction of the building. This sale is expected to close in December 2013.
Acquisition of 10121/10151 Barnes Canyon Road
On July 5, 2013, we acquired 10121/10151 Barnes Canyon Road, an approximate 116,000 RSF office property located in the Sorrento Mesa submarket of San Diego, for a total purchase price of $13.1 million. The acquisition will be funded in two installments: i) $5.4 million to be funded in August, 2013 (which will earn a 7% return until the next payment is made), and ii) $7.7 million to be funded no later than October 2014. The property is currently 100% occupied with leases that expire in 2014 and 2015. We intend to convert the existing office space into laboratory space through redevelopment when the space becomes available. Initial stabilized yields will be provided in the future upon commencement of the redevelopment.
Unsecured senior bank loan financings
On July 26, 2013, we amended our $600 million 2016 Unsecured Senior Bank Term Loan to reduce our interest rate on outstanding borrowings. We did not extend the maturity of this loan as we expect to repay the loan over the next one to three years. In addition, we expect to complete amendments to our $1.5 billion unsecured senior line of credit and our $600 million 2017 Unsecured Senior Bank Term Loan in the third quarter of 2013 to reduce our interest rate on outstanding borrowings, extend the maturity dates and amend certain financial covenants. The commitments available for each facility will not change.
Maturity Date (including extensions) | Applicable Rate | Facility Fee | ||||||||||||
Facility |
Status | Prior/ Current | Extended/ Proposed | Prior/ Current | Extended/ Proposed | Prior/ Current | Extended/ Proposed | |||||||
$600 million 2016 Unsecured Senior Bank Term Loan | Complete | June 2016 | July 2016 | L +1.75% | L +1.20% | N/A | N/A | |||||||
$600 million 2017 Unsecured Senior Bank Term Loan | In Progress | January 2017 | January 2019 | L +1.50% | L +1.20% | N/A | N/A | |||||||
$1.5 billion unsecured senior line of credit | In Progress | April 2017 | January 2019 | L +1.20% | L +1.10% | 0.25% | 0.20% | |||||||
Guidance
Based on our current view of existing market conditions and certain current assumptions, we have updated guidance for earnings per share attributable to Alexandria's common stockholders – diluted and FFO per share attributable to Alexandria's common stockholders – diluted for the year ended December 31, 2013, as set forth in the table below. The table below provides a reconciliation of FFO per share, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure, as well as other key assumptions included in our guidance for the year ended December 31, 2013. To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.
Guidance for the Year Ended December 31, 2013 | Reported on July 29, 2013 | Reported on May 13, 2013 | ||
Earnings per share attributable to Alexandria's common stockholders – diluted | $1.53 to $1.63 | $1.50 to $1.60 | ||
Depreciation and amortization | $2.76 to $2.86 | $2.80 to $2.90 | ||
(Gain) loss on sale of real estate | $(0.01) | $0.01 | ||
Other | $(0.01) | $(0.01) | ||
FFO per share attributable to Alexandria's common stockholders – diluted | $4.32 to $4.42 | $4.35 to $4.45 | ||
Add back: actual 2Q13 per share loss on early extinguishment of debt (1) | $0.01 | N/A | ||
Add back: projected 3Q13 per share loss on early extinguishment of debt (1) | $0.02 | N/A | ||
FFO per share attributable to Alexandria's common stockholders - diluted, as adjusted | $4.35 to $4.45 | $4.35 to $4.45 | ||
Key projection assumptions: | ||||
Same property NOI growth – cash basis | 5% to 7% | 5% to 7% | ||
Same property NOI growth – GAAP basis | 1% to 3% | 1% to 3% | ||
Rental rate steps on lease renewals and re-leasing of space – cash basis | 3% to 5% | 1% to 3% | ||
Rental rate steps on lease renewals and re-leasing of space – GAAP basis | 11% to 13% | 7% to 12% | ||
Occupancy percentage for all operating properties at December 31, 2013 | 94.3% to 94.7% | 94.3% to 94.7% | ||
Straight-line rents | $24 to $26 million | $24 to $26 million | ||
Amortization of above and below market leases | $3 to $4 million | $3 to $4 million | ||
General and administrative expenses | $48 to $51 million | $48 to $51 million | ||
Capitalization of interest | $51 to $57 million | $51 to $57 million | ||
Interest expense, net | $71 to $81 million | $71 to $81 million | ||
Net debt to adjusted EBITDA for the annualized three months ended December 31, 2013 | 6.5x | 6.5x | ||
Fixed charge coverage ratio for the annualized three months ended December 31, 2013 | 3.0x | 3.0x | ||
Non-income-producing land as a percentage of gross real estate by December 31, 2013 | 15% to 17% | 15% to 17% | ||
(1) Represents loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.01 per share as a result of the $150 million partial repayment of our 2016 Unsecured Senior Bank Term Loan during the three months ended June 30, 2013, and the estimated loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.02 per share as a result of amendments of our 2016 Unsecured Senior Bank Term Loan, 2017 Unsecured Senior Bank Term Loan, and $1.5 billion unsecured senior line of credit which we expect to complete in the third quarter of 2013. | ||||
We expect that our principal liquidity needs for the year ended December 31, 2013, will be satisfied by the following multiple sources of capital as shown in the table below. There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.
Reported on July 29, 2013 | Reported on May 13, 2013 | |||||||
Sources and Uses of Capital for the Year Ended December 31, 2013 (in millions) | Completed | Projected | Total | Total | ||||
Sources of capital: | ||||||||
Net cash provided by operating activities less dividends | $ 66 | $ 64 - 84 | $ 130 - 150 | $ 130 - 150 | ||||
Non-income-producing land sales | 18 | 131 - 171 | (1) | 149 - 189 | 149 - 189 | |||
Income producing asset sales | 129 | 0 - 5 | 129 - 134 | 125 - 138 | ||||
Secured construction loan borrowings | 26 | 19 - 39 | 45 - 65 | 45 - 55 | ||||
Unsecured senior notes payable | 500 | − | 500 | 350 - 450 | ||||
Common stock offering | 536 | − | 536 | 415 - 490 | ||||
Available cash and borrowings on unsecured senior line of credit (2) | − | 324 - 369 | 324 - 369 | − | ||||
Total sources of capital | $ 1,275 | $ 538 - 668 | $ 1,813 - 1,943 | $ 1,214 - 1,472 | ||||
Uses of capital: | ||||||||
Development, redevelopment, and construction | $ 253 | $ 346 - 376 | $ 599 - 629 | $ 617 - 667 | ||||
Seller financing of asset sales | 39 | − | 39 | 39 | ||||
Acquisitions: | ||||||||
Completed/in process acquisitions | 13 | 64 | 77 | − | ||||
Additional acquisitions | − | 123 - 223 | 123 - 223 | 200 - 300 | ||||
Secured notes payable repayments | 32 | 5 | 37 | 37 | ||||
Unsecured senior bank term loan repayment | 150 | − | 150 | 125 - 175 | ||||
Excess cash retained from issuance of unsecured senior notes payable/ pay down of unsecured senior line of credit | 788 | − | 788 | 196 - 254 | ||||
Total uses of capital | $ 1,275 | $ 538 - 668 | $ 1,813 - 1,943 | $ 1,214 - 1,472 | ||||
(1) See Balance Sheet section of our Supplemental Package for additional information. | ||||||||
(2) We had $302.2 million in cash and cash equivalents as of June 30, 2013. | ||||||||
The key assumptions behind the sources and uses of capital in the table are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals. Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the "Forward-looking statements" section under Part I, the "Risk Factors" section under Item 1A, and the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2012. We expect to update our forecast of sources and uses of capital on a quarterly basis.
Earnings Call Information
We will host a conference call on Tuesday, July 30, 2013, at 3:00 p.m. Eastern Time ("ET")/12:00 p.m.noon Pacific Time ("PT") that is open to the general public to discuss our financial and operating results for the three months ended June 30, 2013. To participate in this conference call, dial (888) 724-9493 or (913) 312-1456 and confirmation code 7393551, shortly before 3:00 p.m. ET/12:00 p.m.noon PT. The audio web cast can be accessed at: www.are.com, in the "For Investors" section. A replay of the call will be available for a limited time from 6:00 p.m. ET/3:00 p.m. PT on Tuesday, July 30, 2013. The replay number is (888) 203‑1112 or (719) 457-0820 and the confirmation code is 7393551.
Additionally, a copy of this Earnings Press Release and Supplemental Information for the second quarter ended June 30, 2013, is available in the "For Investors" section of our website at www.are.com, or by following this link: http://www.are.com/fs/2013q2.pdf.
About the Company
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade REIT, is the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry. Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria's high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its best-in-class laboratory and office space adjacent to leading academic medical research centers, unparalleled life science real estate expertise and services, and a longstanding and expansive network in the life science community. We believe these advantages result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our 2013 earnings per share attributable to Alexandria's common stockholders − diluted, 2013 FFO per share attributable to Alexandria's common stockholders − diluted, NOI and our projected sources and uses of capital for the year ended December 31, 2013. These forward-looking statements are based on our current expectations, beliefs, projections, future plans, strategies, anticipated events, trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the SEC. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this press release, and we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Consolidated Statements of Income | ||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||
6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | ||||||||
Revenues: | ||||||||||||||
Rental | $ 114,743 | $ 111,776 | $ 112,048 | $ 106,216 | $ 104,329 | $ 226,519 | $ 205,530 | |||||||
Tenant recoveries | 35,923 | 35,611 | 35,721 | 34,006 | 31,881 | 71,534 | 63,763 | |||||||
Other income | 3,569 | 2,993 | 3,785 | 2,628 | 9,383 | 6,562 | 12,011 | |||||||
Total revenues | 154,235 | 150,380 | 151,554 | 142,850 | 145,593 | 304,615 | 281,304 | |||||||
Expenses: | ||||||||||||||
Rental operations | 46,323 | 45,224 | 46,176 | 44,203 | 42,102 | 91,547 | 82,555 | |||||||
General and administrative | 12,472 | 11,648 | 12,635 | 12,470 | 12,298 | 24,120 | 22,655 | |||||||
Interest | 15,978 | 18,020 | 17,941 | 17,092 | 17,922 | 33,998 | 34,148 | |||||||
Depreciation and amortization | 46,580 | 46,065 | 47,515 | 46,584 | 50,741 | 92,645 | 92,527 | |||||||
Impairment of land parcel | − | − | 2,050 | − | − | − | − | |||||||
Loss on early extinguishment of debt | 560 | − | − | − | 1,602 | 560 | 2,225 | |||||||
Total expenses | 121,913 | 120,957 | 126,317 | 120,349 | 124,665 | 242,870 | 234,110 | |||||||
Income from continuing operations | 32,322 | 29,423 | 25,237 | 22,501 | 20,928 | 61,745 | 47,194 | |||||||
Income (loss) from discontinued operations: | ||||||||||||||
Income from discontinued operations before impairment of real estate | 243 | 814 | 5,171 | 5,603 | 4,713 | 1,057 | 9,358 | |||||||
Impairment of real estate | − | − | (1,601) | (9,799) | − | − | − | |||||||
Income (loss) from discontinued operations, net | 243 | 814 | 3,570 | (4,196) | 4,713 | 1,057 | 9,358 | |||||||
Gain on sale of land parcel | 772 | − | − | − | − | 772 | 1,864 | |||||||
Net income | 33,337 | 30,237 | 28,807 | 18,305 | 25,641 | 63,574 | 58,416 | |||||||
Net income attributable to noncontrolling interests | 980 | 982 | 1,012 | 828 | 851 | 1,962 | 1,562 | |||||||
Dividends on preferred stock | 6,471 | 6,471 | 6,471 | 6,471 | 6,903 | 12,942 | 14,386 | |||||||
Preferred stock redemption charge | − | − | − | − | − | − | 5,978 | |||||||
Net income attributable to unvested restricted stock awards | 403 | 342 | 324 | 360 | 271 | 745 | 506 | |||||||
Net income attributable to Alexandria's common stockholders | $ 25,483 | $ 22,442 | $ 21,000 | $ 10,646 | $ 17,616 | $ 47,925 | $ 35,984 | |||||||
Earnings per share attributable to Alexandria's common stockholders – basic and diluted: | ||||||||||||||
Continuing operations | $ 0.38 | $ 0.35 | $ 0.27 | $ 0.24 | $ 0.21 | $ 0.72 | $ 0.43 | |||||||
Discontinued operations, net | − | 0.01 | 0.06 | (0.07) | 0.08 | 0.02 | 0.15 | |||||||
Earnings per share – basic and diluted | $ 0.38 | $ 0.36 | $ 0.33 | $ 0.17 | $ 0.29 | $ 0.74 | $ 0.58 | |||||||
Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria's common stockholders: | ||||||||||||||
– Basic | 66,973 | 63,161 | 63,092 | 62,364 | 61,663 | 65,078 | 61,586 | |||||||
– Diluted | 66,973 | 63,161 | 63,092 | 62,364 | 61,664 | 65,078 | 61,586 | |||||||
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Consolidated Balance Sheets | |||||||||||
June 30, | March 31, | December 31, | September 30, | June 30, | |||||||
2013 | 2013 | 2012 | 2012 | 2012 | |||||||
Assets | |||||||||||
Investments in real estate, net | $ 6,453,379 | $ 6,375,182 | $ 6,424,578 | $ 6,300,027 | $ 6,208,354 | ||||||
Cash and cash equivalents | 302,205 | 87,001 | 140,971 | 94,904 | 80,937 | ||||||
Restricted cash | 30,914 | 30,008 | 39,947 | 44,863 | 41,897 | ||||||
Tenant receivables | 7,577 | 9,261 | 8,449 | 10,124 | 6,143 | ||||||
Deferred rent | 177,507 | 170,100 | 170,396 | 160,914 | 155,295 | ||||||
Deferred leasing and financing costs, net | 164,362 | 159,872 | 160,048 | 152,021 | 151,355 | ||||||
Investments | 122,605 | 123,543 | 115,048 | 107,808 | 104,454 | ||||||
Other assets | 120,740 | 135,952 | 90,679 | 94,356 | 93,304 | ||||||
Total assets | $ 7,379,289 | $ 7,090,919 | $ 7,150,116 | $ 6,965,017 | $ 6,841,739 | ||||||
Liabilities, Noncontrolling Interests, and Equity | |||||||||||
Secured notes payable | $ 711,029 | $ 730,714 | $ 716,144 | $ 719,350 | $ 719,977 | ||||||
Unsecured senior notes payable | 1,048,395 | 549,816 | 549,805 | 549,794 | 549,783 | ||||||
Unsecured senior line of credit | − | 554,000 | 566,000 | 413,000 | 379,000 | ||||||
Unsecured senior bank term loans | 1,200,000 | 1,350,000 | 1,350,000 | 1,350,000 | 1,350,000 | ||||||
Accounts payable, accrued expenses, and tenant security deposits | 368,249 | 367,153 | 423,708 | 376,785 | 348,037 | ||||||
Dividends payable | 52,141 | 43,955 | 41,401 | 39,468 | 38,357 | ||||||
Total liabilities | 3,379,814 | 3,595,638 | 3,647,058 | 3,448,397 | 3,385,154 | ||||||
Commitments and contingencies | |||||||||||
Redeemablenoncontrolling interests | 14,505 | 14,534 | 14,564 | 15,610 | 15,817 | ||||||
Alexandria Real Estate Equities, Inc.'s stockholders' equity: | |||||||||||
Series D Cumulative Convertible Preferred Stock | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | ||||||
Series E Cumulative Redeemable Preferred Stock | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | ||||||
Common stock | 710 | 633 | 632 | 632 | 622 | ||||||
Additional paid-in capital | 3,596,477 | 3,075,860 | 3,086,052 | 3,094,987 | 3,053,269 | ||||||
Accumulated other comprehensive loss | (39,565) | (22,890) | (24,833) | (19,729) | (37,370) | ||||||
Alexandria's stockholders' equity | 3,937,622 | 3,433,603 | 3,441,851 | 3,455,890 | 3,396,521 | ||||||
Noncontrolling interests | 47,348 | 47,144 | 46,643 | 45,120 | 44,247 | ||||||
Total equity | 3,984,970 | 3,480,747 | 3,488,494 | 3,501,010 | 3,440,768 | ||||||
Totalliabilities, noncontrolling interests, and equity | $ 7,379,289 | $ 7,090,919 | $ 7,150,116 | $ 6,965,017 | $ 6,841,739 | ||||||
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Funds From Operations and Adjusted Funds From Operations | ||||||||||||||
The following table presents a reconciliation of net income attributable to Alexandria's common stockholders − basic, the most directly comparable financial measure presented in accordance with GAAP, to FFO attributable to Alexandria's common stockholders − diluted, FFO attributable to Alexandria's common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria's common stockholders – diluted, for the periods below: | ||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||
6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | ||||||||
Net income attributable to Alexandria's common stockholders – basic | $ 25,483 | $ 22,442 | $ 21,000 | $ 10,646 | $ 17,616 | $ 47,925 | $ 35,984 | |||||||
Depreciation and amortization | 46,580 | 46,995 | 48,072 | 48,173 | 52,355 | 93,575 | 95,760 | |||||||
Loss (gain) on sale of real estate | (219) | 340 | − | (1,562) | (2) | 121 | (2) | |||||||
Impairment of real estate | − | − | 1,601 | 9,799 | − | − | − | |||||||
Gain on sale of land parcel | (772) | − | − | − | − | (772) | (1,864) | |||||||
Amount attributable to noncontrolling interests/unvested restricted stock awards: | ||||||||||||||
Net income | 1,383 | 1,324 | 1,336 | 1,188 | 1,122 | 2,707 | 2,068 | |||||||
FFO | (1,437) | (1,064) | (1,109) | (1,148) | (1,133) | (2,501) | (2,305) | |||||||
FFO attributable to Alexandria'scommon stockholders – basic | 71,018 | 70,037 | 70,900 | 67,096 | 69,958 | 141,055 | 129,641 | |||||||
Assumed conversion of 8.00% Unsecured Senior Convertible Notes | 5 | 5 | 5 | 5 | 6 | 10 | 11 | |||||||
FFO attributable to Alexandria's common stockholders – diluted | 71,023 | 70,042 | 70,905 | 67,101 | 69,964 | 141,065 | 129,652 | |||||||
Realized gain on equity investment primarily related to one non-tenant life science entity | − | − | − | − | (5,811) | − | (5,811) | |||||||
Impairment of land parcel | − | − | 2,050 | − | − | − | − | |||||||
Loss on early extinguishment of debt | 560 | − | − | − | 1,602 | 560 | 2,225 | |||||||
Preferred stock redemption charge | − | − | − | − | − | − | 5,978 | |||||||
Allocation to unvested restricted stock awards | (12) | − | (19) | − | 35 | (12) | (20) | |||||||
FFO attributable to Alexandria's common stockholders – diluted, as adjusted | 71,571 | 70,042 | 72,936 | 67,101 | 65,790 | 141,613 | 132,024 | |||||||
Non-revenue-enhancing capital expenditures: | ||||||||||||||
Maintenance building improvements | (337) | (596) | (329) | (935) | (594) | (933) | (804) | |||||||
Tenant improvements and leasing commissions | (2,990) | (882) | (3,170) | (1,844) | (2,148) | (3,872) | (4,167) | |||||||
Straight-line rent revenue | (8,239) | (6,198) | (9,240) | (5,225) | (5,195) | (14,437) | (13,991) | |||||||
Straight-line rent expense on ground leases | 539 | 538 | 471 | 201 | 1,207 | 1,077 | 2,613 | |||||||
Capitalized income from development projects | 9 | 22 | 45 | 50 | 72 | 31 | 550 | |||||||
Amortization of acquired above and below market leases | (830) | (830) | (844) | (778) | (778) | (1,660) | (1,578) | |||||||
Amortization of loan fees | 2,427 | 2,386 | 2,505 | 2,470 | 2,214 | 4,813 | 4,857 | |||||||
Amortization of debt premiums/discounts | 115 | 115 | 110 | 112 | 110 | 230 | 289 | |||||||
Stock compensation | 4,463 | 3,349 | 3,748 | 3,845 | 3,274 | 7,812 | 6,567 | |||||||
Allocation to unvested restricted stock awards | 50 | 19 | 63 | 19 | 15 | 69 | 48 | |||||||
AFFO attributable to Alexandria's common stockholders – diluted | $ 66,778 | $ 67,965 | $ 66,295 | $ 65,016 | $ 63,967 | $ 134,743 | $ 126,408 | |||||||
The following table presents a reconciliation of net income per share attributable to Alexandria's common stockholders − basic, to FFO per share attributable to Alexandria's common stockholders − diluted, FFO per share attributable to Alexandria's common stockholders – diluted, as adjusted, and AFFO per share attributable to Alexandria's common stockholders – diluted, for the periods below. For the computation of the weighted average shares used to compute the per share information, refer to the "Definitions and Other Information" section in our supplemental information: | ||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||
6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | ||||||||
Net income per share attributable to Alexandria's common stockholders – basic | $0.38 | $0.36 | $0.33 | $0.17 | $0.29 | $0.74 | $0.58 | |||||||
Depreciation and amortization | 0.69 | 0.74 | 0.76 | 0.78 | 0.84 | 1.43 | 1.56 | |||||||
Loss (gain) on sale of real estate | − | 0.01 | − | (0.03) | − | 0.01 | − | |||||||
Impairment of real estate | − | − | 0.03 | 0.16 | − | − | − | |||||||
Gain on sale of land parcel | (0.01) | − | − | − | − | (0.01) | (0.03) | |||||||
Amount attributable to noncontrolling interests/unvested restricted stock awards: | ||||||||||||||
Net income | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | |||||||
FFO | (0.02) | (0.02) | (0.02) | (0.02) | (0.02) | (0.04) | (0.04) | |||||||
FFO per share attributable to Alexandria'scommon stockholders – basic | 1.06 | 1.11 | 1.12 | 1.08 | 1.13 | 2.17 | 2.11 | |||||||
Assumed conversion of 8.00% Unsecured Senior Convertible Notes | − | − | − | − | − | − | − | |||||||
FFO per share attributable to Alexandria's common stockholders – diluted | 1.06 | 1.11 | 1.12 | 1.08 | 1.13 | 2.17 | 2.11 | |||||||
Realized gain on equity investment primarily related to one non-tenant life science entity | − | − | − | − | (0.09) | − | (0.09) | |||||||
Impairment of land parcel | − | − | 0.04 | − | − | − | − | |||||||
Loss on early extinguishment of debt | 0.01 | − | − | − | 0.03 | 0.01 | 0.03 | |||||||
Preferred stock redemption charge | − | − | − | − | − | − | 0.10 | |||||||
Allocation to unvested restricted stock awards | − | − | − | − | − | − | − | |||||||
FFO per share attributable to Alexandria's common stockholders – diluted, as adjusted | 1.07 | 1.11 | 1.16 | 1.08 | 1.07 | 2.18 | 2.14 | |||||||
Non-revenue-enhancing capital expenditures: | ||||||||||||||
Maintenance building improvements | (0.01) | (0.01) | (0.01) | (0.01) | (0.01) | (0.01) | (0.01) | |||||||
Tenant improvements and leasing commissions | (0.04) | (0.01) | (0.05) | (0.03) | (0.03) | (0.06) | (0.07) | |||||||
Straight-line rent revenue | (0.12) | (0.10) | (0.15) | (0.08) | (0.08) | (0.22) | (0.23) | |||||||
Straight-line rent expense on ground leases | 0.01 | 0.01 | 0.01 | − | 0.02 | 0.02 | 0.04 | |||||||
Amortization of acquired above and below market leases | (0.01) | (0.01) | (0.01) | (0.01) | (0.01) | (0.03) | (0.03) | |||||||
Amortization of loan fees | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.07 | 0.09 | |||||||
Stock compensation | 0.07 | 0.05 | 0.06 | 0.06 | 0.05 | 0.12 | 0.11 | |||||||
Allocation to unvested restricted stock awards | − | − | − | − | − | − | − | |||||||
Other | − | − | − | − | − | − | 0.01 | |||||||
AFFO per share attributable to Alexandria's common stockholders – diluted | $1.00 | $1.08 | $1.05 | $1.04 | $1.04 | $2.07 | $2.05 | |||||||
SOURCE Rx Communications Group LLC
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Alexandria Real Estate Equities Inc.mehr Nachrichten
Analysen zu Alexandria Real Estate Equities Inc.mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.